semaglutide news today 2025 Do the New Obesity Drugs Pay for Themselves? BioCentury - 2025 catalysts: New

The telehealth provider had introduced the compounded semaglutide pill as a cheaper alternative to Novo Nordisks branded medication

Tambin acta en las clulas beta del pncreas estimulando la secrecin de insulina de forma glucosa-dependiente solo cuando la glucemia est elevada, lo que limita el riesgo de hipoglucemia en modelos de investigacin

Theyre having a hard time eating enough food to actually support their training, she explains

Here are five key facts you should know before starting GLP-1 treatment

Post-workout recovery smoothies Exercise while on GLP-1 medications is non-negotiable for preserving muscle mass

China went from an afterthought to a CEO-level priority. Every drug that went into late-stage testing must have a China plan, an executive at AstraZeneca told The Wall Street Journal in 2018